ABOUT
Eurekabio
Founded in 2014., Eurekabio is a scientific and technological enterprise focusing on the research and development of core technologies and processes in gene and cell therapy.
We are committed to discovering innovative ways into the field of life science through the interdisciplinary of computer science, electronic engineering, nanomaterials, chemical engineering with life science.
We are devoted to make life science and technology evolve rapidly, and solve a series of technical challenges in gene and cell therapy industry.
Cell Therapy Automation System (CellSep PRO)
Eurekabio has developed the CellSepÒ PRO, an automated closed cell processing system, which can process multiple cell processing protocols such as PBMC separation, beads incubation & wash, gene transduction, enrich & wash, fill & finish.
Gene and Cell Therapy (EuLV System)
Eurekabio has developed the EuLVÒ System based on a stable producer cell line for the large-scale production of lentiviral vectors.
The EuLVÒ System fixed the Achilles heel of the large-scale production of lentiviral vectors, greatly improved the production efficiency and product consistency, and significantly reduces the production cost.
Automation and Informatization of Biological Research and Development (EuBioX)
The EuBioX system can achieve high-quality, reproducible results while streamline the workflow and free up laboratory staff by taking over manual, repetitive steps.
Combining customized automation system and software, the EubioX platform can perform the routine operations of cell culture, and realize detection, screening, passage and culture of monoclonal cells.
